PSIX(PSIX)
PSIX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $662M | $805M | $1.02B | $1.43B |
| Low | $658M | $752M | $1.02B | $1.38B |
| High | $664M | $853M | $1.02B | $1.48B |
| EBITDA Avg | $58M | $71M | $90M | $127M |
| Low | $58M | $66M | $90M | $122M |
| High | $59M | $75M | $90M | $131M |
| EBIT Avg | $50M | $61M | $78M | $109M |
| Low | $50M | $57M | $78M | $105M |
| High | $51M | $65M | $78M | $113M |
| Net Income Avg | $55M | $88M | $137M | $311M |
| Low | $52M | $84M | $123M | $296M |
| High | $57M | $92M | $150M | $325M |
| EPS Avg | $2.38 | $3.83 | $5.92 | $13.49 |
| Low | $2.26 | $3.64 | $5.33 | $12.81 |
| High | $2.49 | $4.01 | $6.51 | $14.09 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $207M | $194M | $149M | $176M | $216M | $216M |
| Low | $206M | $194M | $149M | $176M | $215M | $215M |
| High | $208M | $195M | $150M | $177M | $216M | $217M |
| EBITDA Avg | $18M | $17M | $13M | $16M | $19M | $19M |
| Low | $18M | $17M | $13M | $15M | $19M | $19M |
| High | $18M | $17M | $13M | $16M | $19M | $19M |
| EBIT Avg | $16M | $15M | $11M | $13M | $16M | $16M |
| Low | $16M | $15M | $11M | $13M | $16M | $16M |
| High | $16M | $15M | $11M | $13M | $16M | $17M |
| Net Income Avg | $23M | $21M | $10M | $16M | $24M | $26M |
| Low | $23M | $21M | $10M | $16M | $24M | $26M |
| High | $23M | $21M | $10M | $16M | $25M | $26M |
| EPS Avg | $1.01 | $0.91 | $0.45 | $0.68 | $1.06 | $1.12 |
| Low | $1.00 | $0.91 | $0.45 | $0.68 | $1.05 | $1.11 |
| High | $1.02 | $0.91 | $0.45 | $0.68 | $1.07 | $1.13 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |